Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-11-05

Clinical Trial Update: Mechanisms of Palmitoylethanolamide (PEA) to Alter Pain Sensitivity in Knee Osteoarthritis [NA]

View source ↗

Summary

The trial update reports on how palmitoylethanolamide (PEA) may alter pain sensitivity in knee osteoarthritis and notes the University of Maryland, Baltimore-sp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Palmitoylethanolamide (palmitoylethanolamide)

Snippet

Sponsor: University of Maryland, Baltimore | Conditions: Osteoarthritis, Knee | NA | Status: COMPLETED